Aspire Biopharma Holdin-CW27ASBPWPreferred / convertible

13F holders, Q2 2025 (June 30)
29holders +2
5new positions
3sold out
1famous investor
$0.05avg. 13F price*

At the end of Q2 2025, 29 institutions reported holding Aspire Biopharma Holdin-CW27 (ASBPW) in their 13F filings, up 2 from Q1 2025. 5 opened new positions and 3 sold out. The largest holders were Adage Capital Partners Gp, L.L.C. ($47K), Saba Capital Management, L.P. ($44K) and Linden Advisors LP ($41K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).

Company
Aspire Biopharma Holdin-CW27
CUSIP
738920115
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q1 2025: 27Q1 2025Q2 2025: 29Q2 2025Q3 2025: 29Q3 2025Q4 2025: 29Q4 2025Q1 2026: 29Q1 2026Q2 2026: 27Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions5$34K
Exits3$17K

All 13F filers, Q1 2025 → Q2 2025: 766,897 shares bought and 2,438,723 shares sold, net −1,671,826 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 29 holders
Adage Capital Partners Gp, L.L.C. — No change 1,050,000 $47K
Saba Capital Management, L.P. — No change 983,603 $44K
Linden Advisors LP — No change 899,999 $41K
Aristeia Capital, L.L.C. — No change 681,516 $31K
Toronto Dominion Bank — New 516,845 $23K
Sculptor Capital LP — Reduce -79.2% 500,000 $22K
Verition Fund Management LLC — No change 432,757 $19K
Barclays PLC — No change 350,000 $16K
Clear Street LLC — No change 331,064 $15K
Taconic Capital Advisors LP — No change 300,000 $13K
D. E. Shaw & Co. — No change 199,999 $9K
Wolverine Asset Management LLC — No change 195,944 $9K
Context Capital Management, LLC — No change 175,000 $8K
Mint Tower Capital Management B.V. — No change 25,000 $7K
Nomura Holdings Inc. — New 150,000 $7K
Polar Asset Management Partners Inc. — No change 138,536 $6K
Athos Capital Ltd — No change 21,383 $6K
Periscope Capital Inc. — Reduce -69.4% 124,924 $6K
LMR Partners LLP — No change 125,000 $6K
Whitebox Advisors LLC — No change 118,750 $5K
Clear Street Derivatives LLC — No change 106,000 $5K
VR Advisory Services Ltd — New 99,692 $4K
Limestone Investment Advisors LP — — 75,000 $3K
Blue Owl Capital Holdings LP — No change 50,000 $2K
OMERS ADMINISTRATION Corp — No change 25,000 $1K
Flow Traders U.S. LLC — Add +2.1% 14,491 $1K
Picton Mahoney Asset Management — No change 50,000 $1K
Osaic Holdings, Inc. — New 50 $2
Investors Research Corp — New 10 $0

"% of holder's portfolio" is ASBPW's weight in each manager's 13F, not the share of Aspire Biopharma Holdin-CW27 the manager owns.